01/14/2025
7:36 PM | Context Therapeutics (Issuer)
Pasternak Andy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/14/2025
7:43 PM | Context Therapeutics (Issuer)
Pasternak Andy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
4:03 PM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:37 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:07 PM | Context Therapeutics (Subject)
MPM BioImpact LLC (Filed by)
| Form SCHEDULE 13G | |
12/23/2024
8:26 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:20 PM | Context Therapeutics (Filer)
| Form 424B5 | |
12/02/2024
3:21 PM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:15 PM | Context Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
3:52 PM | Context Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A | |
11/06/2024
4:08 PM | Context Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
| Form SC 13G/A | |
|
11/06/2024
3:42 PM | Context Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/23/2024
6:33 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
3:22 PM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
7:15 AM | Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:01 AM | Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2024
7:04 AM | Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:08 AM | Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/04/2024
6:34 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
4:15 PM | Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2024
4:18 PM | Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
4:07 PM | Context Therapeutics (Filer)
| Form DEFA14A | |
07/24/2024
3:55 PM | Context Therapeutics (Filer)
| Form DEF 14A | |
07/10/2024
6:33 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
6:52 AM | Context Therapeutics (Issuer)
Stacey Jennifer Evans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:41 AM | BERMAN RICHARD J (Reporting)
Context Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:47 AM | Context Therapeutics (Issuer)
West Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:50 AM | Context Therapeutics (Issuer)
Kantoff Philip W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:34 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
9:45 AM | Context Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G | |
06/02/2024
11:15 PM | Context Therapeutics (Filer)
| Form EFFECT | |
05/24/2024
6:31 AM | Context Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/13/2024
9:37 AM | Avidity Partners Management LP (Filed by)
Context Therapeutics (Subject)
| Form SC 13G | |
05/02/2024
6:37 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:16 PM | Context Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:12 PM | Context Therapeutics (Filer)
| Form DEFA14A | |
04/01/2024
6:32 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
7:01 AM | Context Therapeutics (Issuer)
Lehr Martin A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:01 AM | Context Therapeutics (Issuer)
Levit Alex C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:04 AM | Context Therapeutics (Issuer)
Minai-Azary Jennifer Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
7:28 AM | Context Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
24/7 Automated Profits in Crypto (Ad) What if you could make consistent daily profits in crypto with minimal effort?
Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life. >> Secure Your Spot On The Groundbreaking Workshop Here |
03/21/2024
6:36 AM | Context Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
6:31 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | Context Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
3:24 PM | Context Therapeutics (Subject)
Lehr Martin A. (Filed by)
| Form SC 13G/A | |
